این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Physiology and Pharmacology، جلد ۱۲، شماره ۴، صفحات ۲۹۶-۳۰۶
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی CYP2A6 genetic polymorphism and its relation to risk of smoking dependence in male Iranians
چکیده انگلیسی مقاله Introduction: Nicotine is the psychoactive substance responsible for establishing and maintaining smoking dependence. CYP2A6 is the primary enzyme that inactivates nicotine to cotinine .Genetic variation in CYP2A6 accounts for some of the inter-individual variability in nicotine metabolism and has been indicated to influence smoking behavior and dependence. Therefore, the aim of this study was to examine whether there is a relationship between CYP2A6 genetic polymorphism and smoking dependence in an Iranian population. Methods: We assessed 118 male non-smokers (1-99 cigarette/ lifetime) and 133 dependent current smokers for demographic, cigarette use history and DSM-IV dependence. CYP2A6 alleles associated with decreased nicotine metabolism (* 2, *4, or *9 allele) were determined using allele-specific nested PCR. Genotypes were grouped into slow metabolizers (one or two copies of *2 or *4, or two *9 alleles), intermediate (one *9 allele), and normal (have no copies of *2 , *4 , or *9 alleles). Results: Intermediate nicotine metabolizers were at higher risk for becoming a dependent smoker odd ratio (OR = 3.71 p=0.009). Slow metabolizers had a significantly lower age of first smoking compared to normal and intermediate metabolizers (p = 0.037). Cigarette consumption and the degree of smoking dependence were not significantly different among smokers with different CYP2A6 genotypes. Conclusion: In Iranian population, the risk for becoming a dependent smokers increases with genotypes for intermediate metabolism of nicotine and slow nicotine metabolizers experience smoking in lower ages. These findings increase our understanding of the effect of CYP2A6 genotypes on smoking dependence in Iranian population and may help us to develop new strategies for quitting smoking.
کلیدواژه‌های انگلیسی مقاله CYP2A6, Polymorphism, smoking, Iranians
نویسندگان مقاله معصومه امام قریشی | masoumeh emamghoreishi
department of pharmacology, medical school, shiraz university of medical sciences, shiraz, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (Shiraz university of medical sciences)

حمیدرضا بکایی | hamid reza bokaee
department of pharmacology


مجتبی کشاورز | mojtaba keshavarz
department of pharmacology
نشانی اینترنتی http://www.phypha.ir/ppj/browse.php?a_code=A-10-204-2&slc_lang=en&sid=en
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده Cellular and Molecular BioMedicine
نوع مقاله منتشر شده Original Research
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات